PROCEPT BioRobotics Corp (PRCT) stock
PRCTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3049% below fair value
$23.78+0.24 (+1.02%)
Close on Nov 17, 2026Market cap $1.36BP/E –Yield –
PROCEPT BioRobotics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
PROCEPT BioRobotics's revenue for the twelve months ending Jun 30, 2026 was $337.34M, up 22.7% year over year. For fiscal 2025 it was $308.05M, up 37.2% from the year before. The highest annual figure on record is $308.05M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $308.05M | +37.2% |
| FY2024 | Dec 31, 2024 | $224.50M | +64.8% |
| FY2023 | Dec 31, 2023 | $136.19M | +81.6% |
| FY2022 | Dec 31, 2022 | $75.01M | +117.6% |
| FY2021 | Dec 31, 2021 | $34.47M | +346.7% |
| FY2020 | Dec 31, 2020 | $7.72M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $94.50M | +19.3% |
| Q1 FY2026 | Mar 31, 2026 | $83.13M | +20.2% |
| Q4 FY2025 | Dec 31, 2025 | $76.38M | +11.9% |
| Q3 FY2025 | Sep 30, 2025 | $83.33M | +42.8% |
| Q2 FY2025 | Jun 30, 2025 | $79.18M | +48.4% |
| Q1 FY2025 | Mar 31, 2025 | $69.16M | +55.3% |
| Q4 FY2024 | Dec 31, 2024 | $68.24M | +56.6% |
| Q3 FY2024 | Sep 30, 2024 | $58.37M | +66.3% |
| Q2 FY2024 | Jun 30, 2024 | $53.35M | +61.2% |
| Q1 FY2024 | Mar 31, 2024 | $44.54M | +82.5% |
| Q4 FY2023 | Dec 31, 2023 | $43.58M | +83.3% |
| Q3 FY2023 | Sep 30, 2023 | $35.10M | +72.5% |
| Q2 FY2023 | Jun 30, 2023 | $33.10M | +98.3% |
| Q1 FY2023 | Mar 31, 2023 | $24.40M | +71.9% |
| Q4 FY2022 | Dec 31, 2022 | $23.78M | +134.5% |
| Q3 FY2022 | Sep 30, 2022 | $20.35M | +134.8% |
| Q2 FY2022 | Jun 30, 2022 | $16.69M | +96.9% |
| Q1 FY2022 | Mar 31, 2022 | $14.20M | +97.4% |
| Q4 FY2021 | Dec 31, 2021 | $10.14M | +214.7% |
| Q3 FY2021 | Sep 30, 2021 | $8.67M | +311.4% |
| Q2 FY2021 | Jun 30, 2021 | $8.48M | – |
| Q1 FY2021 | Mar 31, 2021 | $7.19M | – |
| Q4 FY2020 | Dec 31, 2020 | $3.22M | – |
| Q3 FY2020 | Sep 30, 2020 | $2.11M | – |
See a number that looks wrong?